Select Medical Holdings Corpora

Valuation Analysis

About the Company

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clin

Select Medical Holdings Corpora Stock at a Glance

Select Medical Holdings Corpora (SEM) is currently trading at $16.66 with a market capitalization of $2.1B. The trailing P/E ratio stands at 15.57x, with a forward P/E of 12.14x. The 52-week range spans from $11.65 to $16.99; the current price is 1.9% below the yearly high. Year-over-year revenue growth stands at +5.0%. The net profit margin stands at 2.42%.

💰 Dividend

Select Medical Holdings Corpora pays an annual dividend of $0.25 per share, representing a yield of 1.5%. The payout ratio stands at 23.36%.

📊 Analyst Rating

4 analysts rate Select Medical Holdings Corpora (SEM) on consensus: None. The average price target is $16.62, implying -0.21% from the current price. Analyst price targets range from $16.50 to $17.00.

Select Medical Holdings Corpora: The Investment Case in Detail

Select Medical Holdings Corpora (SEM) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

The Bear Case

With a net margin of just 2.42%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

What to Watch Next

• The forward P/E of 12.14x is meaningfully below the trailing 15.57x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 93.8% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Select Medical Holdings Corpora?

Compare top-rated brokers — low fees, trusted providers, fully regulated.